45 results on '"Böger, Rainer H"'
Search Results
2. Serum reference intervals of homoarginine, ADMA, and SDMA in the Study of Health in Pomerania
3. Genetic and Environmental Determinants of Dimethylarginines and Association With Cardiovascular Disease in Patients With Type 2 Diabetes
4. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: Results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study
5. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency
6. Reloaded: ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inaemia: effects of L-arginine and B vitamins
7. Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort
8. Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort
9. The role of asymmetric and symmetric dimethylarginines in renal disease
10. Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension
11. Extensive characterization of the human DDAH1 transgenic mice
12. Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—An update on patient populations with a wide range of cardiovascular risk
13. Asymmetric dimethylarginine: Understanding the physiology, genetics, and clinical relevance of this novel biomarker: Proceedings of the 4th International Symposium on ADMA
14. A myeloperoxidase promoter polymorphism is independently associated with mortality in patients with impaired left ventricular function
15. Urinary excretion of biomarkers of oxidatively damaged DNA and RNA in hereditary hemochromatosis
16. Association of Plasma ADMA Levels With MRI Markers of Vascular Brain Injury: Framingham Offspring Study
17. Nitroxyl exacerbates ischemic cerebral injury and oxidative neurotoxicity
18. Association of the Endogenous Nitric Oxide Synthase Inhibitor ADMA With Carotid Artery Intimal Media Thickness in the Framingham Heart Study Offspring Cohort
19. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy
20. Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)
21. P2Y12 polymorphisms and antiplatelet effects of aspirin in patients with coronary artery disease
22. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism
23. Acute effects of various fast-food meals on vascular function and cardiovascular disease risk markers: the Hamburg Burger Trial1–3
24. Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F2trans-isoprostane in hypercholesterolaemic patients
25. The Pharmacodynamics of L-Arginine1-3
26. Mechanisms of Disease: L-arginine in coronary atherosclerosis-a clinical perspective
27. Pharmacokinetics of Oral Doses of Telmisartan and Nisoldipine, Given Alone and in Combination, in Patients With Essential Hypertension
28. Urinary Excretion of 8-oxodG and 8-oxoGuo as Biomarkers of Oxidatively Damaged DNA and RNA in Hereditary Haemachromatosis (HH): 371
29. Renal impairment: a challenge for opioid treatment? The role of buprenorphine
30. Renal impairment: a challenge for opioid treatment? The role of buprenorphine
31. Elevated levels of asymmetric dimethylarginine (ADMA) as a marker of cardiovascular disease and mortality
32. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events
33. Cerebral Vascular Dysfunction Mediated by Superoxide in Hyperhomocysteinemic Mice
34. Plasma Concentrations of Asymmetric Dimethylarginine (ADMA) in Colombian Women With Pre-eclampsia
35. Clinical Pharmacokinetics of Antioxidants and Their Impact on Systemic Oxidative Stress
36. Application of Gas Chromatography-Mass Spectrometry for Analysis of Isoprostanes: Their Role in Cardiovascular Disease
37. Association of Asymmetric Dimethylarginine and Endothelial Dysfunction
38. Marked Increase of Asymmetric Dimethylarginine in Patients with Incipient Primary Chronic Renal Disease
39. Relationship of asymmetric dimethylarginine to dialysis treatment and atherosclerotic disease
40. Asymmetric Dimethylarginine, Derangements of the Endothelial Nitric Oxide Synthase Pathway, and Cardiovascular Diseases
41. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship
42. Effect of captopril on prostacyclin and nitric oxide formation in healthy human subjects: Interaction with low dose acetylsalicylic acid
43. Recombinant human erythropoietin enhances vasoconstrictor tone via endothelin-1 and constrictor prostanoids
44. Urinary nitrate excretion is increased in cardiac transplanted patients with acute graft rejection
45. URINARY NO3- EXCRETION AS AN INDICATOR OF NITRIC OXIDE FORMATION IN VIVO DURING ORAL ADMINISTRATION OF L-ARGININE OR L-NAME IN RATS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.